April 19, 2025
How Our Obsession With Being Thin Drives Pharma Profits
GLP-1 drugs Ozempic and Wegovy made Novo Nordisk Europe's biggest company, with Eli Lilly's Zepbound now challenging in
March 3, 2024
The Weight-Loss Drug Craze: Impact on the Food Industry
Appetite-suppressing drugs like Wegovy and Ozempic rattled Coca-Cola, PepsiCo, and snack makers, though past diet trends
January 12, 2024
How New Obesity Drugs Are Revolutionizing Weight Loss
Semaglutide drugs like Wegovy and Ozempic mimic a gut hormone to curb appetite, helping patients lose 15% of body weight
October 31, 2023
Novo Nordisk and Semaglutide: Transforming Obesity Care
Semaglutide, sold as Ozempic and Wegovy, drove $10.7B in spending and made Novo Nordisk Europe most valuable company, re